Private Equity: Capital Driver of Healthcare Technology
Presented by New England Healthcare Executive Network
Date/Time
March 4, 2019 7:30AM–10:00AM
Description
Co-sponsored with Harvard Business School Association of Boston
Hear from industry leaders on the latest trends in PE investments from 2018 and predictions for 2019.
Private Equity (PE) investment funds are major players in the growth path of healthcare technology companies. Bruce Robertson, Managing Director of H.I.G. BioHealth Partners, will be the keynote speaker. H.I.G. is one of the largest PE firms in the world.
Following Bruce Robertson’s remarks, a panel will share their experiences working with PE firms. The panel includes CEOs who have lead med tech companies with PE investors. Paul LaViolette, SV Health Investors, Gabriele Brambilla, CEO of Alira Health will be on the panelist.
Keynote Speaker
Bruce Robertson, Managing Director of H.I.G. BioHealth Partners
Bruce focuses on investment opportunities in the life sciences sector, including biopharmaceuticals, medical devices, and diagnostics. Bruce currently serves on the boards of Apollo Endosurgery, RxSight, CardioFocus, Clarus Therapeutics, and Iconic Therapeutics.
Moderator
Rick Williams, Managing Director, Williams Advisory Partners, LLC
Rick is a CEO and board advisor. Nationally published thought leader on preparing to raise capital, overcoming barriers to growth and preparing for the sale of the company.
Panelists
Gabriele Brambilla, Chief Executive Officer, Alira Health
Alira Health is an international advisory firm providing integrated strategy, execution and innovation services for healthcare and life science companies.
Tom Burns, President & Chief Executive Officer, Resonetics
Tom joined Resonetics in 2012 as CEO, bringing 25 years of experience in the medical device and contract manufacturing industries.
Paul LaViolette, Managing Partner, Chief Operating Officer, SV Health Investors
Paul brings over 35 years of global medical technology management experience to SV. Prior to joining SV in 2009 Paul built and ran medical device businesses. Most recently he was Chief Operating Officer at Boston Scientific (BSC).
Come join this timely, lively, keynote presentation and blue-ribbon panel discussion. Ask questions and contribute your insights during the interactive audience segment.
What to Expect
Private Equity funds are one of the options company leaders consider when making strategic capital decisions. The speakers will address these topics among others:
- Where in the life cycle of a healthcare company do PE investors usually enter,
- What is the profile of a company of interest to a PE investor,
- Do PE firms only look at cash flow positive companies,
- Are there sectors of the healthcare space that PE likes and does not like,
- What does a PE investor mean to me and my company,
- Private Equity and M&A Outlook: Trends and Opportunities.
Who should attend
CEOs, CFO’s, board members, business owners, venture capital investors, investment bankers and corporate executives who want a better understanding of how to maximize their opportunities with Private Equity (PE) investment.
Click here for more details.